company background image
2737 logo

Sunflower Pharmaceutical GroupLtd XSEC:002737 Stock Report

Last Price

CN¥26.32

Market Cap

CN¥15.4b

7D

-2.6%

1Y

24.4%

Updated

25 Mar, 2024

Data

Company Financials

Sunflower Pharmaceutical Group Co.,Ltd

XSEC:002737 Stock Report

Market Cap: CN¥15.4b

2737 Stock Overview

Sunflower Pharmaceutical Group Co.,Ltd engages in the research and development, manufacturing, and marketing of Chinese patent medicines in China and internationally.

2737 fundamental analysis
Snowflake Score
Valuation4/6
Future Growth0/6
Past Performance6/6
Financial Health6/6
Dividends4/6

Sunflower Pharmaceutical Group Co.,Ltd Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Sunflower Pharmaceutical GroupLtd
Historical stock prices
Current Share PriceCN¥26.32
52 Week HighCN¥30.32
52 Week LowCN¥20.54
Beta0.33
1 Month Change-0.87%
3 Month Change2.45%
1 Year Change24.39%
3 Year Change92.68%
5 Year Change36.73%
Change since IPO46.88%

Recent News & Updates

Recent updates

Shareholder Returns

2737CN PharmaceuticalsCN Market
7D-2.6%-1.6%-0.03%
1Y24.4%-8.6%-14.2%

Return vs Industry: 002737 exceeded the CN Pharmaceuticals industry which returned -8.6% over the past year.

Return vs Market: 002737 exceeded the CN Market which returned -14.2% over the past year.

Price Volatility

Is 2737's price volatile compared to industry and market?
2737 volatility
2737 Average Weekly Movement4.9%
Pharmaceuticals Industry Average Movement6.9%
Market Average Movement8.1%
10% most volatile stocks in CN Market11.3%
10% least volatile stocks in CN Market5.1%

Stable Share Price: 002737 has not had significant price volatility in the past 3 months.

Volatility Over Time: 002737's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
20055,278Yi Guanhttps://www.kuihuayaoye.com

Sunflower Pharmaceutical Group Co.,Ltd engages in the research and development, manufacturing, and marketing of Chinese patent medicines in China and internationally. The company produces chemical and biological medicines, and health care products. It also provides products covering various therapeutic areas, including pediatrics, gynecology, digestive system, respiratory and cold, rheumatic bone disease, and cardiovascular and cerebrovascular; supplements; and antibiotics and children’s medicinal products.

Sunflower Pharmaceutical Group Co.,Ltd Fundamentals Summary

How do Sunflower Pharmaceutical GroupLtd's earnings and revenue compare to its market cap?
2737 fundamental statistics
Market capCN¥15.37b
Earnings (TTM)CN¥1.21b
Revenue (TTM)CN¥6.10b

12.7x

P/E Ratio

2.5x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
2737 income statement (TTM)
RevenueCN¥6.10b
Cost of RevenueCN¥2.60b
Gross ProfitCN¥3.50b
Other ExpensesCN¥2.29b
EarningsCN¥1.21b

Last Reported Earnings

Sep 30, 2023

Next Earnings Date

Apr 26, 2024

Earnings per share (EPS)2.07
Gross Margin57.36%
Net Profit Margin19.82%
Debt/Equity Ratio0.2%

How did 2737 perform over the long term?

See historical performance and comparison

Dividends

3.8%

Current Dividend Yield

48%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.